Tuesday, March 25, 2014 9:58:12 AM
Another piece of information is regarding VasoPet: the company is clearly still trying to determine what they are going to do within this "valuable therapeutic area of plaque imaging". They state that, "in light of the limited remaining patent life and our cash constraints, we are not currently allocating resources to this program." Again, not devastating news because we were always mainly focused on CardioPet and BFPET development.
Cash declarations stay consistent with company reiterating that they have enough cash through August '14. The rest of the 10K is quite standard and I will reread it again this evening when I get home from work.
Have a great day everyone!!!
RR
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM